NASDAQ:SIEN - Sientra Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$6.80 -0.09 (-1.31 %)
(As of 05/23/2019 03:31 PM ET)
Previous Close$6.89
Today's Range$6.75 - $7.04
52-Week Range$6.41 - $26.79
Volume29,029 shs
Average Volume673,401 shs
Market Capitalization$198.70 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.1
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIEN
CUSIPN/A
Phone805-562-3500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$68.13 million
Book Value$1.45 per share

Profitability

Net Income$-82,630,000.00
Net Margins-126.32%

Miscellaneous

Employees259
Market Cap$198.70 million
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable

Sientra (NASDAQ:SIEN) Frequently Asked Questions

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

How were Sientra's earnings last quarter?

Sientra Inc (NASDAQ:SIEN) released its quarterly earnings data on Wednesday, May, 8th. The medical instruments supplier reported ($0.91) EPS for the quarter, missing the Zacks' consensus estimate of ($0.76) by $0.15. The medical instruments supplier earned $17.55 million during the quarter, compared to the consensus estimate of $17 million. Sientra had a negative net margin of 126.32% and a negative return on equity of 119.59%. View Sientra's Earnings History.

When is Sientra's next earnings date?

Sientra is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Sientra.

What price target have analysts set for SIEN?

8 brokers have issued twelve-month target prices for Sientra's shares. Their predictions range from $9.00 to $30.00. On average, they anticipate Sientra's stock price to reach $21.00 in the next year. This suggests a possible upside of 208.8% from the stock's current price. View Analyst Price Targets for Sientra.

What is the consensus analysts' recommendation for Sientra?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

Has Sientra been receiving favorable news coverage?

News stories about SIEN stock have trended somewhat positive on Thursday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sientra earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an impact on the stock's share price in the next several days.

Who are some of Sientra's key competitors?

What other stocks do shareholders of Sientra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Regions Financial (RF), Verizon Communications (VZ), Baidu (BIDU), Allergan (AGN), ChemoCentryx (CCXI), Genocea Biosciences (GNCA), Novavax (NVAX), Alibaba Group (BABA), Oasis Petroleum (OAS) and Idera Pharmaceuticals (IDRA).

Who are Sientra's key executives?

Sientra's management team includes the folowing people:
  • Mr. Jeffrey M. Nugent, Chairman & CEO (Age 72)
  • Mr. Charles Huiner, COO and Sr. VP of Corp. Devel. & Strategy (Age 48)
  • Mr. Keith J. Sullivan, Director & Advisor to MiraDry Bus. (Age 61)
  • Mr. Paul Sean Little, CFO, Sr. VP & Treasurer (Age 54)
  • Ms. Deborah Bettencourt, VP of Customer Experience & Corp. Admin.

Who are Sientra's major shareholders?

Sientra's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.45%), Goldman Sachs Group Inc. (1.65%), Gilder Gagnon Howe & Co. LLC (1.41%), Northern Trust Corp (1.01%), Geode Capital Management LLC (0.98%) and HighTower Advisors LLC (0.96%). Company insiders that own Sientra stock include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

Which institutional investors are selling Sientra stock?

SIEN stock was sold by a variety of institutional investors in the last quarter, including Gilder Gagnon Howe & Co. LLC, Morgan Stanley, Marshall Wace LLP, Blair William & Co. IL, Wells Fargo & Company MN, BlackRock Inc., New York State Common Retirement Fund and Parametric Portfolio Associates LLC. Company insiders that have sold Sientra company stock in the last year include Jeffrey M Nugent and Timothy Haines. View Insider Buying and Selling for Sientra.

Which institutional investors are buying Sientra stock?

SIEN stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Dimensional Fund Advisors LP, JPMorgan Chase & Co., Stephens Inc. AR, Quantum Capital Management, HighTower Advisors LLC, BlueMountain Capital Management LLC and Marshall Wace North America L.P.. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $6.80.

How big of a company is Sientra?

Sientra has a market capitalization of $198.70 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.

What is Sientra's official website?

The official website for Sientra is http://www.sientra.com/.

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]


MarketBeat Community Rating for Sientra (NASDAQ SIEN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  232 (Vote Underperform)
Total Votes:  427
MarketBeat's community ratings are surveys of what our community members think about Sientra and other stocks. Vote "Outperform" if you believe SIEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/23/2019 by MarketBeat.com Staff

Featured Article: What is a conference call?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel